149 related articles for article (PubMed ID: 17292846)
1. [Diagnostic procedures and more particularly, place of scintigraphy in neuroendocrine tumors, example of vipoma in MEN 1].
Rigabert J; De Clermont H
Ann Endocrinol (Paris); 2007 Jun; 68(2-3):199-203. PubMed ID: 17292846
[TBL] [Abstract][Full Text] [Related]
2. Acute renal failure as an initial manifestation of multiple endocrine neoplasia (MEN) type 1.
Afshar R; Sanavi S; Taheri HR
Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):117-21. PubMed ID: 22237232
[TBL] [Abstract][Full Text] [Related]
3. Overview of chronic diarrhea caused by functional neuroendocrine neoplasms.
Jensen RT
Semin Gastrointest Dis; 1999 Oct; 10(4):156-72. PubMed ID: 10548409
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype.
Sala E; Ferrante E; Verrua E; Malchiodi E; Mantovani G; Filopanti M; Ferrero S; Pietrabissa A; Vanoli A; La Rosa S; Zatelli MC; Beck-Peccoz P; Verga U
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):858-62. PubMed ID: 23542451
[TBL] [Abstract][Full Text] [Related]
5. Gastric Neuroendocrine Tumors in MEN1 Syndrome: Cinematic Rendering.
Chu LC; Fishman EK
Radiology; 2018 Jun; 287(3):748. PubMed ID: 29782244
[No Abstract] [Full Text] [Related]
6. VIPoma.
Mishra BM
N Engl J Med; 2004 Dec; 351(24):2558. PubMed ID: 15590967
[No Abstract] [Full Text] [Related]
7. Preliminary evaluation of the usefulness of Tc-99m (V) DMSA in pancreatic neuroendocrine tumors.
Banci M; Bianchi PL; Gianni W; Romani AM; De Vincentis G; Ierardi M; Scopinaro F
Clin Nucl Med; 1996 Feb; 21(2):122-4. PubMed ID: 8697681
[TBL] [Abstract][Full Text] [Related]
8. Multiple endocrine neoplasia type 1 with gastric neuroendocrine tumor presented with gastric polyposis.
Liu CT; Chiu YC; Chen YY
Clin Gastroenterol Hepatol; 2015 May; 13(5):e45. PubMed ID: 25460558
[No Abstract] [Full Text] [Related]
9. [Symptoms and diagnosis of neuroendocrine tumors of the digestive system].
Gyökeres T
Orv Hetil; 2011 Mar; 152(10):371-8. PubMed ID: 21354953
[TBL] [Abstract][Full Text] [Related]
10. [Neuroendocrine tumors of the digestive system].
Prónai L; Rácz K; Tulassay Z
Orv Hetil; 2002 May; 143(19 Suppl):1081-6. PubMed ID: 12063866
[TBL] [Abstract][Full Text] [Related]
11. Multiple endocrine neoplasia type 1.
Doherty GM
J Surg Oncol; 2005 Mar; 89(3):143-50. PubMed ID: 15719382
[TBL] [Abstract][Full Text] [Related]
12. Ventricular fibrillation resulting from electrolyte imbalance reveals vipoma in MEN1 syndrome.
Cavalli T; Giudici F; Santi R; Nesi G; Brandi ML; Tonelli F
Fam Cancer; 2016 Oct; 15(4):645-9. PubMed ID: 27071757
[TBL] [Abstract][Full Text] [Related]
13. Triple Tracer Positivity in Metastatic Lymph Nodes from Well-Differentiated Neuroendocrine Tumor in MEN-1 Syndrome.
Kavanal AJ; Bhadada SK; Sood A; Kaur G; Parwaiz A; Gulati A; Dahiya D; Mittal BR
J Nucl Med Technol; 2020 Sep; 48(3):287-289. PubMed ID: 32111661
[TBL] [Abstract][Full Text] [Related]
14. MEN 1 and 2: the role of diagnostic imaging.
Gollini P; Cataldi A; Fava C
Radiol Med; 2004; 107(1-2):78-87. PubMed ID: 15031699
[TBL] [Abstract][Full Text] [Related]
15. The early diagnosis of multiple endocrine neoplasia type 1 (MEN 1): a case report.
Tamagno G; De Carlo E; Martini C; Rubello D; Fallo F; Sicolo N
J Endocrinol Invest; 2004 Oct; 27(9):878-82. PubMed ID: 15648555
[TBL] [Abstract][Full Text] [Related]
16. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
Desai KK; Khan MS; Toumpanakis C; Caplin ME
Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
[TBL] [Abstract][Full Text] [Related]
17. A case of vasoactive intestinal peptide-secreting tumor (VIPoma) arising from MEN1 inactivation which recurred 15 years after the initial resection.
Sakurai M; Wakabayashi T; Kondo Y; Ikeda E; Watanabe K; Takei A; Okazaki H; Okada K; Ebihara K; Kakiuchi N; Ogawa S; Fukushima N; Ishibashi S
Endocr J; 2023 Jun; 70(6):573-579. PubMed ID: 36889692
[TBL] [Abstract][Full Text] [Related]
18. Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors.
de Laat JM; Tham E; Pieterman CR; Vriens MR; Dorresteijn JA; Bots ML; Nordenskjöld M; van der Luijt RB; Valk GD
Eur J Endocrinol; 2012 Aug; 167(2):181-7. PubMed ID: 22581216
[TBL] [Abstract][Full Text] [Related]
19. Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1.
Yates CJ; Newey PJ; Thakker RV
Lancet Diabetes Endocrinol; 2015 Nov; 3(11):895-905. PubMed ID: 26165399
[TBL] [Abstract][Full Text] [Related]
20. Use of the sestamibi scan to identify hyperplastic parathyroid tissue in the forearm of a patient with MEN1 syndrome.
Norton KS; Zibari GB; Johnson LW
J La State Med Soc; 2001 Dec; 153(12):605-7. PubMed ID: 11804454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
